Kepos Capital LP Alkermes Plc. Transaction History

Kepos Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$13.06 - $21.24 $291,303 - $473,758	-22,305 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $846,109 - $1.05 Million	-43,368 Reduced 66.04%	22,305 $435,000
Q2 2019 Aug 13, 2019	SELL	$21.47 - $37.33 $21 - $37	-1 Reduced -0.0%	65,673 $1.48 Million
Q1 2019 May 13, 2019	SELL	$28.4 - $36.49 $28 - $36	-1 Reduced -0.0%	65,674 $2.4 Million
Q4 2018 Feb 13, 2019	BUY	$27.94 - $44.61 $1.83 Million - $2.93 Million	65,675 New	65,675 $1.94 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.